Discovery of an Allosteric Agonist for Schizophrenia Risk Gene GPR52 with Antipsychotic Activity

被引：0
|
作者：
Murphy, Ryan E. [1 ]
Felsing, Daniel E. [1 ]
Dvorak, Nolan M. [1 ]
Laezza, Fernanda [1 ]
Cunningham, Kathryn A. [1 ]
Allen, John A. [1 ]
机构：
[1] Univ Texas Med Branch, Houston, TX USA
来源：
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 2023年 / 385卷
关键词：
D O I：
10.1124/jpet.122.278870
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
537
引用
收藏
页数：1
相关论文
共 47 条
  • [21] Allosteric coupling between G-protein binding and extracellular ligand binding sites in GPR52 revealed by 19F-NMR and cryo-electron microscopy
    Fan, Yanliu
    Lin, Xi
    Pan, Benxun
    Chen, Bo
    Liu, Dongsheng
    Wuethrich, Kurt
    Xu, Fei
    MEDCOMM, 2023, 4 (02):
  • [22] The schizophrenia risk gene ZNF804A influences the antipsychotic response of positive schizophrenia symptoms
    Rainald Mössner
    Anna Schuhmacher
    Michael Wagner
    Leonhard Lennertz
    Anja Steinbrecher
    Boris B. Quednow
    Dan Rujescu
    Marcella Rietschel
    Wolfgang Maier
    European Archives of Psychiatry and Clinical Neuroscience, 2012, 262 : 193 - 197
  • [23] The schizophrenia risk gene ZNF804A influences the antipsychotic response of positive schizophrenia symptoms
    Moessner, Rainald
    Schuhmacher, Anna
    Wagner, Michael
    Lennertz, Leonhard
    Steinbrecher, Anja
    Quednow, Boris B.
    Rujescu, Dan
    Rietschel, Marcella
    Maier, Wolfgang
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2012, 262 (03) : 193 - 197
  • [24] Discovery of TAK-041: Potent and Selective GPR139 Agonist for Treatment of Negative Symptoms Associated With Schizophrenia
    Siekmeier, Peter
    Lowen, Steven
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 486 - 487
  • [25] Discovery of TAK-041: Potent and selective GPR139 agonist for treatment of negative symptoms associated with schizophrenia
    Reichard, Holly
    Monenschein, Holger
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [26] Discovery of TAK-041: a Potent and Selective GPR139 Agonist Explored for the Treatment of Negative Symptoms Associated with Schizophrenia
    Reichard, Holly A.
    Schiffer, Hans H.
    Monenschein, Holger
    Atienza, Josephine M.
    Corbett, Gerard
    Skaggs, Alton W.
    Collia, Deanna R.
    Ray, William J.
    Serrats, Jordi
    Bliesath, Joshua
    Kaushal, Nidhi
    Lam, Betty P.
    Amador-Arjona, Alejandro
    Rahbaek, Lisa
    McConn, Donavon J.
    Mulligan, Victoria J.
    Brice, Nicola
    Gaskin, Philip L. R.
    Cilia, Jackie
    Hitchcock, Stephen
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (15) : 11527 - 11542
  • [27] EFFECT OF CFMTI, AN ALLOSTERIC METABOTROPIC GLUTAMATE RECEPTOR 1 ANTAGONIST WITH ANTIPSYCHOTIC ACTIVITY, ON Fos EXPRESSION IN REGIONS OF THE BRAIN RELATED TO SCHIZOPHRENIA
    Suzuki, G.
    Satow, A.
    Ohta, H.
    NEUROSCIENCE, 2010, 168 (03) : 787 - 796
  • [28] The antipsychotic-like activity of VU152100, a muscarinic M4 receptor positive allosteric modulator, in animal models of schizophrenia
    Wieronska, J. M.
    Wozniak, M.
    Cieslik, P.
    Pilc, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S528 - S529
  • [29] Discovery of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Reveals Chemical and Functional Diversity and In Vivo Activity in Rat Behavioral Models of Anxiolytic and Antipsychotic Activity
    Rodriguez, Alice L.
    Grier, Mark D.
    Jones, Carrie K.
    Herman, Elizabeth J.
    Kane, Alexander S.
    Smith, Randy L.
    Williams, Richard
    Zhou, Ya
    Marlo, Joy E.
    Days, Emily L.
    Blatt, Tasha N.
    Jadhav, Satyawan
    Menon, Usha N.
    Vinson, Paige N.
    Rook, Jerri M.
    Stauffer, Shaun R.
    Niswender, Colleen M.
    Lindsley, Craig W.
    Weaver, C. David
    Conn, P. Jeffrey
    MOLECULAR PHARMACOLOGY, 2010, 78 (06) : 1105 - 1123
  • [30] THE ROLE OF IMAGING GENETICS IN UNANTICIPATED SCHIZOPHRENIA RISK GENE DISCOVERY: TNIK AND MICRORNA-137
    Potkin, Steven G.
    Macciardi, Fabio
    van Erp, Theo
    Keator, David
    Guffanti, Guia
    Xie, Xiaohui
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S62 - S62
12345